secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K/A
Filed at:   2023-06-30T23:59:59+00:00
Accession:  0001493152-23-023175
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO pro forma shows $6.2M revenue and $9.2M net loss for combined WFI acquisition in FY2022
--------------------------------------------------------------------------------

- Combined pro forma revenue for FY2022: $6.20M ($822k INVO + $5.38M WFI); net loss of $9.21M vs INVO standalone loss of $10.89M.
- Total purchase consideration of $10M, with $2.5M upfront and $7.5M payable over three years; sellers may take stock at set prices.
- Preliminary goodwill of $10.06M recorded; purchase price allocation subject to final valuation within 12 months.
- Pro forma for Q1 2023: combined revenue $1.69M, net loss $2.09M; compared to INVO standalone revenue $0.35M and loss $2.55M.
- WFI (WFRSA + FLOW) had audited FY2022 revenue of $5.38M and net income of $1.68M on a standalone basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223023175/0001493152-23-023175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223023175/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-023175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer